Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease

American Journal of Cardiology

Volumn 77, Issue 5, 1996, Pages 350-354

  Matsunari, Ichiro ^a   Fujino, Susumu ^b   Taki, Junichi ^b   Senma, Junji ^b   Aoyama, Takahiko ^b   Wakasugi, Takanobu ^b   Hirai, Jun Ichi ^b   Saga, Takashi ^b   Tonami, Norihisa ^b   Hisada, Kinichi ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; EXERCISE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030049255     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89362-9     Document Type: Article

References (22)

1. Brown KA, Rowen M. Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing non-cardiac surgery. J Am Coll Cardiol 1993;21:325-330.
2. Iskandrian AS, Heo J, Decoskey D, Askenase A, Segel BL. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease. Am J Cardiol 1988;61:269-272.
3. Iskandrian AS, Hakki AH, Kane-Marsch S. Prognostic implications of exercise thallium-201 scintigraphy in patients with suspected or known coronary artery disease. Am Heart J 1985;110:135-143.
4. Hendel RC, Chen MH, L'Italien GJ, Newell JB, Paul SD, Eagle KA, Leppo JA. Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients: an analysis of clinical and scintigraphic variables. Circulation 1995;91:1044-1051.
5. Higley B, Smith FW, Smith T, Gemmell HG, Dupta PD, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A. Technetium-99m-1, 2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-38.
6. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, Chiu KW, Edwards B, Gill HK, McPartlin M, Nagle KR, Latham IA, Pickett RD, Storey AE, Webbon PM. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-227.
7. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254-1259.
8. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993;34:1478-1484.
9. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m-tetrofosimin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994;35:587-593.
10. Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura E, Yonekura Y, Okuda K, Nohara R, Sasayama S, Konishi J. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35:594-600.
11. 201Tl imaging and coronary angiography in a phase in multicenter trial. Circulation 1995;91:313-319.
12. Narahara KA, Villanueva-Meyer J, Thompson CJ, Brizindine M, Mena I. Comparison of thallium-201 and technetium-99m hexakis 2-methoxyisobutyl isonitrile single-photon emission computed tomography for estimating the extent of myocardial ischemia and infarction in coronary artery disease. Am J Cardiol 1990;66:1438-1444.
13. Maublant JC, Marcaggi X, Lusson JR, Boire JY, Cauvin JC, Jacob P, Veyre A, Cassagnes J. Comparison between thallium-201 and technetium-99m methoxy-isobutyl isonitrile defect size in single-photon emission computed tomography at rest, exercise and redistribution in coronary artery disease. Am J Cardiol 1992;69:183-187.
14. Weich HF, Strauss HW, Pitt B. The extraction of thallium-201 by the myocardium. Circulation 1977;56:188-191.
15. Sinusas AJ, Shi Q-X, Saltzberg MT, Vitols P, Jain D, Wackers FJT, Zaret BL. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35: 664-671.
16. Leon AR, Eisner RL, Martin SE, Schmarkey LS, Aaron AM, Boyers AS, Burnham KM, Oh DJ, Patterson RE. Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs. J Am Coll Cardiol 1992;20:1612-1625.
17. Tsui BMW, Gullberg GT, Edgerton ER, Ballard JG, Perry JR, McCartney WH, Berg J. Correction of nonuniform attenuation in cardiac SPECT imaging. J Nucl Med 1989;30:1813-1820.
18. Wallis JW, Miller TR, Koppel P. Attenuation correction in cardiac SPECT without a transmission measurement. J Nucl Med 1995;36:506-512.
19. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-146.
20. Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990;66:158-163.
21. Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med 1990;31:1617-1623.
22. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konishi J. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-399.